期刊
EMBO MOLECULAR MEDICINE
卷 4, 期 1, 页码 3-14出版社
WILEY-BLACKWELL
DOI: 10.1002/emmm.201100191
关键词
antagomir; antimir; cardiovascular disease; microRNA; therapeutics
资金
- German Ministry for Education and Research [01EO0802]
- German Research Foundation [TH903/10-1]
Cardiovascular diseases are the most common causes of human morbidity and mortality despite significant therapeutic improvements by surgical, interventional and pharmacological approaches in the last decade. MicroRNAs (miRNAs) are important and powerful mediators in a wide range of diseases and thus emerged as interesting new drug targets. An array of animal and even human miRNA-based therapeutic studies has been performed, which validate miRNAs as being successfully targetable to treat a wide range of diseases. Here, the current knowledge about miRNAs therapeutics in cardiovascular diseases on their way to clinical use are reviewed and discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据